Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Cardiovasc Pharmacol Ther ; 13(2): 94-7, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18495904

ABSTRACT

Hypotension is commonly encountered during carotid artery stenting (CAS), mediated by vagal stimulation and suppression of sympathetic outflow. Some patients require treatment with intravenous vasopressors (dopamine, nor-epinephrine, or phenylephrine). The authors describe the successful use of the oral agent midodrine as an alternative to intravenous vasopressors in the treatment of hypotension related to CAS. Of 55 patients who underwent elective CAS, 19 (35%) experienced significant hypotension, and 15 (27%) required vasopressor therapy. Eleven patients received intravenous dopamine infusion in an intensive care setting, whereas 4 received oral midodrine in a regular telemetry unit. All patients eventually recovered and were discharged without any residual cardiovascular or neurological complications. No major side effects were noted with the use of both dopamine and midodrine. Cost of hospitalization was significantly higher in the dopamine group because of the need for ICU admission.


Subject(s)
Hypotension/drug therapy , Midodrine/therapeutic use , Stents/adverse effects , Vasoconstrictor Agents/therapeutic use , Administration, Oral , Aged , Aged, 80 and over , Cardiotonic Agents/adverse effects , Cardiotonic Agents/economics , Cardiotonic Agents/therapeutic use , Carotid Stenosis/surgery , Dopamine/adverse effects , Dopamine/economics , Dopamine/therapeutic use , Female , Hospital Costs , Humans , Hypotension/etiology , Infusions, Intravenous , Intensive Care Units/economics , Male , Midodrine/adverse effects , Midodrine/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...